{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:00:24Z","timestamp":1790676024079,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0647-1","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T12:03:07Z","timestamp":1440590587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Loss of tapasin correlates with diminished CD8+ T-cell immunity and prognosis in colorectal cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Lena","family":"Sokol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor H.","family":"Koelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman T.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Karamitopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inti","family":"Zlobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"647_CR1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(87)90552-6","volume":"1","author":"JR Jass","year":"1987","unstructured":"Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303\u20136.","journal-title":"Lancet"},{"key":"647_CR2","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohou\u00e9 F, Bruneval P, Cugnenc P-H, Trajanoski Z, Fridman W-H, Pag\u00e8s F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960\u20134.","journal-title":"Science"},{"key":"647_CR3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","volume":"29","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman W-H, Pag\u00e8s F, Galon J. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29:610\u20138.","journal-title":"J Clin Oncol"},{"key":"647_CR4","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.4049\/jimmunol.171.10.5287","volume":"171","author":"AL Zarling","year":"2003","unstructured":"Zarling AL, Luckey CJ, Marto JA, White FM, Brame CJ, Evans AM, Lehner PJ, Cresswell P, Shabanowitz J, Hunt DF, Engelhard VH. Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J Immunol. 2003;171:5287\u201395.","journal-title":"J Immunol"},{"key":"647_CR5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0105-2896.2005.00316.x","volume":"207","author":"P Cresswell","year":"2005","unstructured":"Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev. 2005;207:145\u201357.","journal-title":"Immunol Rev"},{"key":"647_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1074-7613(02)00263-7","volume":"16","author":"TP Dick","year":"2002","unstructured":"Dick TP, Bangia N, Peaper DR, Cresswell P. Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. Immunity. 2002;16:87\u201398.","journal-title":"Immunity"},{"key":"647_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1074-7613(00)00021-2","volume":"13","author":"AG Grandea","year":"2000","unstructured":"Grandea AG, Golovina TN, Hamilton SE, Sriram V, Spies T, Brutkiewicz RR, Harty JT, Eisenlohr LC, Van Kaer L. Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity. 2000;13:213\u201322.","journal-title":"Immunity"},{"key":"647_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0161-5890(02)00103-7","volume":"39","author":"F Momburg","year":"2002","unstructured":"Momburg F, Tan P. Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum. Mol Immunol. 2002;39:217\u201333.","journal-title":"Mol Immunol"},{"key":"647_CR9","isbn-type":"print","volume-title":"Janeway\u2019s Immunobiology","author":"K Murphy","year":"2011","unstructured":"Murphy K. Janeway\u2019s Immunobiology. New York, NY: Garland Science, Taylor & Francis Group, LLC. 2011. ISBN: 978-0815345312.","ISBN":"https:\/\/id.crossref.org\/isbn\/9780815345312"},{"key":"647_CR10","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1158\/0008-5472.CAN-04-3977","volume":"65","author":"Y Lou","year":"2005","unstructured":"Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, Jeffries AP, Elliott WM, Atkins D, Seliger B, Jefferies WA. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Cancer Res. 2005;65:7926\u201333.","journal-title":"Cancer Res"},{"key":"647_CR11","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/1078-0432.CCR-07-1066","volume":"14","author":"Y Lou","year":"2008","unstructured":"Lou Y, Basha G, Seipp RP, Cai B, Chen SS, Moise AR, Jeffries AP, Gopaul RS, Vitalis TZ, Jefferies WA. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival. Clin Cancer Res. 2008;14:1494\u2013501.","journal-title":"Clin Cancer Res"},{"key":"647_CR12","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/bjc.2013.197","volume":"108","author":"VH Koelzer","year":"2013","unstructured":"Koelzer VH, Karamitopoulou E, Dawson HE, Kondi-Pafiti A, Zlobec I, Lugli A. Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer. Br J Cancer. 2013;108:2088\u201396.","journal-title":"Br J Cancer"},{"key":"647_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1479-5876-11-104","volume":"11","author":"I Zlobec","year":"2013","unstructured":"Zlobec I, Koelzer VH, Dawson HE, Perren A, Lugli A. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. J Transl Med. 2013;11:104.","journal-title":"J Transl Med"},{"issue":"2","key":"647_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trsl.2015.02.008","volume":"166","author":"VH Koelzer","year":"2015","unstructured":"Koelzer VH, Dawson HE, Andersson E, Karamitopoulou E, Masucci GV, Lugli A, Zlobec I. Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome. Transl Res. 2015;166(2):207\u201317. doi: 10.1016\/j.trsl.2015.02.008","journal-title":"Transl Res."},{"key":"647_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00292-010-1278-1","volume":"31","author":"J R\u00fcschoff","year":"2010","unstructured":"R\u00fcschoff J, Nagelmeier I, Baretton G, Dietel M, H\u00f6fler H, Schildhaus HU, B\u00fcttner R, Schlake W, Stoss O, Kreipe HH. Her2 testing in gastric cancer. What is different in comparison to breast cancer? Pathologe. 2010;31:208\u201317.","journal-title":"Pathologe"},{"key":"647_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.11681","volume":"109","author":"D Atkins","year":"2004","unstructured":"Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, St\u00f6rkel S, Seliger B. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer. 2004;109:265\u201373.","journal-title":"Int J Cancer"},{"key":"647_CR17","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-07-4433","volume":"14","author":"LY Han","year":"2008","unstructured":"Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res. 2008;14:3372\u20139.","journal-title":"Clin Cancer Res"},{"key":"647_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00403-003-0393-8","volume":"295","author":"J Dissemond","year":"2003","unstructured":"Dissemond J, Kothen T, M\u00f6rs J, Weimann TK, Lindeke A, Goos M, Wagner SN. Downregulation of tapasin expression in progressive human malignant melanoma. Arch Dermatol Res. 2003;295:43\u20139.","journal-title":"Arch Dermatol Res"},{"key":"647_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2174\/1871520614666140825110402","volume":"14","author":"C Thuring","year":"2014","unstructured":"Thuring C, Geironson L, Paulsson K. Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme. Anticancer Agents Med Chem. 2014;14:1101\u20139.","journal-title":"Anticancer Agents Med Chem"},{"key":"647_CR20","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.12086","volume":"62","author":"M M\u00fcller","year":"2013","unstructured":"M\u00fcller M, Agaimy A, Zenk J, Ettl T, Iro H, Hartmann A, Seliger B, Schwarz S. The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases. Histopathology. 2013;62:847\u201359.","journal-title":"Histopathology"},{"key":"647_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2007.02746.x","volume":"124","author":"A Belicha-Villanueva","year":"2008","unstructured":"Belicha-Villanueva A, McEvoy S, Cycon K, Ferrone S, Gollnick SO, Bangia N. Differential contribution of TAP and tapasin to HLA class I antigen expression. Immunology. 2008;124:112\u201320.","journal-title":"Immunology"},{"key":"647_CR22","first-page":"1","volume-title":"Momburg F","author":"N Garbi","year":"2000","unstructured":"Garbi N, Tan P, Diehl AD, Chambers BJ, Ljunggren H. Momburg F. H\u00e4mmerling GJ: Impaired immune responses and altered peptide repertoire in tapasin-deficient mice; 2000. p. 1."},{"key":"647_CR23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ni1485","volume":"8","author":"PA Wearsch","year":"2007","unstructured":"Wearsch PA, Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol. 2007;8:873\u201381.","journal-title":"Nat Immunol"},{"key":"647_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0854.2009.01025.x","volume":"11","author":"SM Rizvi","year":"2010","unstructured":"Rizvi SM, Raghavan M. Mechanisms of function of tapasin, a critical major histocompatibility complex class I assembly factor. Traffic. 2010;11:332\u201347.","journal-title":"Traffic"},{"key":"647_CR25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93:387\u201391.","journal-title":"Br J Cancer"},{"key":"647_CR26","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/modpathol.2012.94","volume":"25","author":"B Mitrovic","year":"2012","unstructured":"Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol. 2012;25:1315\u201325.","journal-title":"Mod Pathol"},{"key":"647_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1034\/j.1399-0039.2003.00020.x","volume":"61","author":"CM Cabrera","year":"2003","unstructured":"Cabrera CM, Jim\u00e9nez P, Cabrera T, Esparza C, Ruiz-Cabello F, Garrido F. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7\/TAP2 downregulation in MSI-negative tumors. Tissue Antigens. 2003;61:211\u20139.","journal-title":"Tissue Antigens"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0647-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T21:09:09Z","timestamp":1567112949000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0647-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]},"article-number":"279"}}